HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bérangère Bastien Selected Research

TG4010

1/2017Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.
2/2016TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
1/2015Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial.
11/2011Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bérangère Bastien Research Topics

Disease

5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 11/2011
2Neoplasms (Cancer)
01/2017 - 01/2015
2Neutropenia
02/2016 - 11/2011
2Fatigue
02/2016 - 11/2011
1Sepsis (Septicemia)
01/2022
1Chronic Hepatitis B
01/2020
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017
1Melanoma (Melanoma, Malignant)
01/2017
1Neuroblastoma
01/2017
1Injection Site Reaction
02/2016
1Vaccinia
02/2016
1Disease Progression
01/2015
1Anorexia
11/2011
1Abdominal Pain (Pain, Abdominal)
11/2011
1Pleural Effusion (Pleural Effusions)
11/2011
1Pain (Aches)
11/2011
1Fever (Fevers)
11/2011

Drug/Important Bio-Agent (IBA)

4TG4010IBA
01/2017 - 11/2011
3VaccinesIBA
01/2020 - 01/2015
2AntigensIBA
01/2017 - 02/2016
2Interleukin-2 (IL2)IBA
01/2017 - 02/2016
1Interleukin-7 (Interleukin 7)IBA
01/2022
1Viral VaccinesIBA
01/2017
1Mucin-1 (CA 15-3 Antigen)IBA
01/2017
1EpitopesIBA
01/2017
1Natural Killer Cell ReceptorsIBA
01/2017

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2017 - 11/2011
2Immunotherapy
01/2022 - 02/2016
1Punctures
01/2022
1Ligation
01/2022
1Therapeutics
01/2015